| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/01/2003 | CN1122534C Method for reducing side effects of drug |
| 10/01/2003 | CN1122531C Method for industrially producing Japanese encephalitis vaccine, and resulting vaccine |
| 10/01/2003 | CN1122530C Vacines |
| 09/30/2003 | US6627741 Isolated antibody or fragment thereof that specifically binds to a protein with a specified amino acid sequence, as well as a hybridoma encoding it |
| 09/30/2003 | US6627733 Receptor tyrosine kinase with a discoidin-type binding domain |
| 09/30/2003 | US6627730 Of given amino acid sequence, and diagnostic test kit; multidrug resistance |
| 09/30/2003 | US6627728 BASB010 polypeptides; fusion proteins; use in vaccines against bacterial infections including otitis media; related by sequence homology to TlyC hemolysin protein of Serpulina hyodysenteriae |
| 09/30/2003 | US6627619 Cancer diagnosis |
| 09/30/2003 | US6627615 Methods and compositions for in vivo gene therapy |
| 09/30/2003 | US6627605 Polynucleotides which encode them, and methods for their use. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention further provides methods for diagnosing or treating disorders with |
| 09/30/2003 | US6627439 Cancer diagnosis, therapy; Dna vaccine |
| 09/30/2003 | US6627415 Isolated nucleic acid comprising a nucleotide sequence encoding fibrinogen-like domain; use in diagnosis and treatment of tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammationinflammation |
| 09/30/2003 | US6627405 53BP2 complexes |
| 09/30/2003 | US6627403 Detecting hyperplasia in tissue sample; obtain tissue sample, isolate nucleotide sequence, detect chymotryptic nucleotide sequences, presence of sequences indicates hyperplasia |
| 09/30/2003 | US6627205 Ovo vaccination against coccidiosis |
| 09/30/2003 | US6627204 Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses |
| 09/30/2003 | US6627203 Non-virulent culture of Arthrobacter |
| 09/30/2003 | US6627202 HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 09/30/2003 | US6627198 Therapy, prevention tuberculosis infections |
| 09/30/2003 | US6627196 Dosages for treatment with anti-ErbB2 antibodies |
| 09/30/2003 | US6627195 Binding agents to CD23 |
| 09/30/2003 | US6627194 Activated immunoglobulin |
| 09/30/2003 | CA2133759C Evaluation and treatment of patients with progressive immunosuppression |
| 09/25/2003 | WO2003079025A2 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof |
| 09/25/2003 | WO2003079020A2 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer |
| 09/25/2003 | WO2003078658A2 Methods for diagnosing and treating schizophrenia |
| 09/25/2003 | WO2003078640A2 Recombinant drug-sensitive vaccinia virus as smallpox vaccine |
| 09/25/2003 | WO2003078632A1 Novel receptor polypeptides and polynucleotides encoding the same |
| 09/25/2003 | WO2003078600A2 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 09/25/2003 | WO2003078595A2 Immunostimulatory double stranded rna and methods of inducing, enhancing or modulating the immune response |
| 09/25/2003 | WO2003078469A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof |
| 09/25/2003 | WO2003078465A1 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1 |
| 09/25/2003 | WO2003078455A2 Virus like particle from papillomavirus and their use in vaccine |
| 09/25/2003 | WO2003078453A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 09/25/2003 | WO2003077947A1 Methods of modulating cd200 receptors |
| 09/25/2003 | WO2003077946A1 Medicinal agent and method for curing pathologic syndrome associated to hemodyscrasia |
| 09/25/2003 | WO2003077944A1 Improvements in vaccination |
| 09/25/2003 | WO2003077943A2 Method for the production of a pharmaceutical preparation by adsorption in a poorly soluble aluminum compound |
| 09/25/2003 | WO2003077942A2 Virus-like particles of human papillomavirus |
| 09/25/2003 | WO2003077859A2 Method of inducing an enhanced immune response against hiv |
| 09/25/2003 | WO2003077841A2 Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases |
| 09/25/2003 | WO2003077838A2 Hiv-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and immunogens |
| 09/25/2003 | WO2003077836A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/25/2003 | WO2003077834A2 Central airway administration for systemic delivery of therapeutics |
| 09/25/2003 | WO2003077723A2 Methods and devices for detection and therapy of atheromatous plaque |
| 09/25/2003 | WO2003077658A1 Re-activated t-cells for adoptive immunotherapy |
| 09/25/2003 | WO2003042246A3 Inhibitors of the notch signalling pathway for use in the treatment of cancer |
| 09/25/2003 | WO2003041735A3 Composotion comprising inhibitors of the notch signalling pathway for the modulation of the immune system |
| 09/25/2003 | WO2003018064A3 Lipophilic drug compositions |
| 09/25/2003 | WO2003013594A3 Modulation of antibody formation in mammals, applicability in gene therapy and animal model generation |
| 09/25/2003 | WO2003013577A3 Use of il-18 inhibitors in hypersensitivity disorders |
| 09/25/2003 | WO2003011331A3 Materials and methods relating to improved vaccination strategies |
| 09/25/2003 | WO2003004627A3 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 09/25/2003 | WO2003000907A3 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 09/25/2003 | WO2002099116A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/25/2003 | WO2002097081A3 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production |
| 09/25/2003 | WO2002092826A3 Composition and method for treating cancer using herpes virus |
| 09/25/2003 | WO2002092635A3 Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens |
| 09/25/2003 | WO2002092628A3 Plasmodium falciparum antigens and vaccine and diagnostic uses thereof |
| 09/25/2003 | WO2002077263A3 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
| 09/25/2003 | WO2002076482A3 USE OF IKK-β INHIBITORS AND METHOD FOR DISCOVERY OF SAID INHIBITORS |
| 09/25/2003 | WO2002064634A3 Human monoclonal antibodies to fc alpha receptor (cd89) |
| 09/25/2003 | WO2002064612A9 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 09/25/2003 | WO2002062368A3 Method of inducing a ctl response |
| 09/25/2003 | WO2002060921A3 Enhancement of immune response to vaccine by interferon alpha |
| 09/25/2003 | WO2002053587A3 Polypeptide inducing hiv-neutralising antibodies |
| 09/25/2003 | WO2002030964A3 Comparative ligand mapping from mhc positive cells |
| 09/25/2003 | WO2002028355A3 Methods and compositions for enhancing angiogenesis |
| 09/25/2003 | WO2002016420A3 Antiviral compounds derived from the hsv gd protein and methods |
| 09/25/2003 | WO2002016411A3 Binding polypeptides and methods based thereon |
| 09/25/2003 | WO2002014361A3 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 83P2H3 AND CaTrF2E11 USEFUL IN TREATMENT AND DETECTION OF CANCER |
| 09/25/2003 | US20030182671 Method of constructing mouse suitable for the take, differentiation and proliferation of heterogenous cells, mouse constructed by this method and use of the mouse |
| 09/25/2003 | US20030181706 Inflammation-associated polynucleotides |
| 09/25/2003 | US20030181687 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 09/25/2003 | US20030181665 Which lack N-glycosidase-rRNA activity; kits |
| 09/25/2003 | US20030181662 Human procalcitonin and the preparation and use thereof |
| 09/25/2003 | US20030181661 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 09/25/2003 | US20030181659 Thrombopoietin receptor modulating peptide |
| 09/25/2003 | US20030181658 Exhibit protease activity as a single chain or as an activated two chain form; use of polypeptides to identify compounds that modulate the protease activity thereof and as tumor markers |
| 09/25/2003 | US20030181409 Methods of inhibiting fertility |
| 09/25/2003 | US20030181406 Immunostimulants, synthetic oligonucleotide or polynucleotide for treating infectious diseases, allergy, asthma, cancer, anemia, thrombocytopenia, or neutropenia |
| 09/25/2003 | US20030181379 Novel fibroblast growth factor (FGF23) and methods for use |
| 09/25/2003 | US20030181370 H-Y antigen |
| 09/25/2003 | US20030181362 Receptor |
| 09/25/2003 | US20030180948 Superficial zone protein and methods of making and using same |
| 09/25/2003 | US20030180934 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 09/25/2003 | US20030180880 Chromosome 1 gene and gene products related to alzheimer's disease |
| 09/25/2003 | US20030180817 Determining levels of a colon specific gene in the cells, or bodily fluids in a patient, comparing determined levels of CSG with levels of CSG in cells from normal human control, wherein a change in level of CSG indicates presence of cancer |
| 09/25/2003 | US20030180799 Antibodies against plasma cells |
| 09/25/2003 | US20030180792 Fusion proteins; PRO polypeptides; fibroblast/nerve growth factor receptors |
| 09/25/2003 | US20030180785 Polynucleotide molecules encoding Neospora proteins |
| 09/25/2003 | US20030180778 UDP-N-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R/ (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3 |
| 09/25/2003 | US20030180759 Antigen derived from the gp160 env precursor protein (glycoprotein120 envelop protein)of a HIV-1 group O strain contains an amino acid sequence characterized by the fact that it reacts with antibodies raised against such antigen |
| 09/25/2003 | US20030180755 Pharmaceutical compositions in particulate form |
| 09/25/2003 | US20030180752 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/25/2003 | US20030180736 Methods for the early diagnosis of ovarian cancer |
| 09/25/2003 | US20030180690 Method and tools for oral hygiene |
| 09/25/2003 | US20030180372 Water in oil emulsion; inoculating lymph nodes of pregnancy goat with virus |
| 09/25/2003 | US20030180351 Pharmaceutically active composition and dispensing device |
| 09/25/2003 | US20030180330 Method for identifying helicobacter antigens |